ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

From trouble with the waterworks to deadly cancer, the prostate seems to attract trouble for men. Why? And what’s to be done ...

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said that an advisory panel of the European Medicines Agency (EMA), endorsed its Itovebi ...

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care.

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

Population breast cancer screening using mammography, alongside effective treatment, has been shown to reduce breast cancer ...

A new genetic test called MammaPrint is helping many breast cancer patients. This test determines the risk of cancer ...

Learn about the symptoms, causes, and treatments for yeast infection under the breast. Get tips on prevention and effective ...

The days of prolonged waiting for breast cancer detection results and additional MRI exams could soon be coming to an end for ...

Dr Mariana Chavez MacGregor looks ahead to early-stage breast cancer updates, including optimization strategies and emerging approaches to improve patient care.